SPHDF fundamentals
SANTHERA PHARMACEUTICALS HOLDING AG financial statements, including revenue, expenses, profit, and loss
The total revenue of SPHDF for the last semiannual is 118.11 M USD, and it's 2585.02% higher compared to the previous semiannual. The net income of H2 23 is 92.78 M USD.
0.00
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
TTM